A very large diversity space of synthetically accessible compounds for use with drug design programs
- 1 January 2005
- journal article
- Published by Springer Nature in Journal of Computer-Aided Molecular Design
- Vol. 19 (1) , 47-63
Abstract
We have constructed a very large virtual diversity space containing more than 1013 chemical compounds. The diversity space is built from about 400 combinatorial libraries, which have been expanded by choosing sizeable collections of suitable R-groups that can be attached to each link point of their scaffolds. These R-group collections have been created by selecting reagents that have drug-like properties from catalogs of available chemicals. As members of known combinatorial libraries, the compounds in the diversity space are in general synthetically accessible and useful as potential drug leads. Hence, the diversity space can be used as a vast source of compounds by a de novo drug design program. For example, we have used such a program to generate inhibitors of HIV integrase enzyme that exhibited activity in the micromolar range.Keywords
This publication has 32 references indexed in Scilit:
- Virtual screening and fast automated docking methodsDrug Discovery Today, 2002
- LigBuilder: A Multi-Purpose Program for Structure-Based Drug DesignJournal of Molecular Modeling, 2000
- Efficient combinatorial filtering for desired molecular properties of reaction productsJournal of Molecular Graphics and Modelling, 2000
- Implementation of a System for Reagent Selection and Library Enumeration, Profiling, and DesignJournal of Chemical Information and Computer Sciences, 1999
- Beyond Mere Diversity: Tailoring Combinatorial Libraries for Drug DiscoveryJournal of Combinatorial Chemistry, 1998
- CombiDOCK: Structure-based combinatorial docking and library designJournal of Computer-Aided Molecular Design, 1998
- PRO_SELECT: Combining structure-based drug design and combinatorial chemistry for rapid lead discovery. 1. TechnologyJournal of Computer-Aided Molecular Design, 1997
- PRO_LIGAND: An approach to de novo molecular design. 1. Application to the design of organic moleculesJournal of Computer-Aided Molecular Design, 1995
- De Novo Design of Enzyme Inhibitors by Monte Carlo Ligand GenerationJournal of Medicinal Chemistry, 1995
- Automatic creation of drug candidate structures based on receptor structure. Starting point for artificial lead generation.Tetrahedron, 1991